ABSTRACT
Neutrophils are thought to be involved in many infectious diseases and have been found in high numbers in the corneas of patients with Acanthamoeba keratitis. Using a Chinese hamster model of keratitis, conjunctival neutrophil migration was manipulated to determine the importance of neutrophils in this disease. Inhibition of neutrophil recruitment was achieved by subconjunctival injection with an antibody against macrophage inflammatory protein 2 (MIP-2), a powerful chemotactic factor for neutrophils which is secreted by the cornea. In other experiments, neutrophils were depleted by intraperitoneal injection of anti-Chinese hamster neutrophil antibody. The inhibition of neutrophils to the cornea resulted in an earlier onset and more severe infection compared to controls. Anti-MIP-2 antibody treatment produced an almost 35% reduction of myeloperoxidase activity in the cornea 6 days postinfection, while levels of endogenous MIP-2 secretion increased significantly. Recruitment of neutrophils into the cornea via intrastromal injections of recombinant MIP-2 generated an initially intense inflammation that resulted in the rapid resolution of the corneal infection. The profound exacerbation of Acanthamoeba keratitis seen when neutrophil migration was inhibited, combined with the rapid clearing of the disease in the presence of increased neutrophils, strongly suggests that neutrophils play an important role in combating Acanthamoeba infections in the cornea.
Subject(s)
Acanthamoeba Keratitis/therapy , Antibodies/therapeutic use , Chemokines/antagonists & inhibitors , Neutrophils/physiology , Animals , Cell Movement , Chemokine CXCL2 , Chemokines/physiology , Complement System Proteins/physiology , Cricetinae , Cricetulus , Immune Sera/immunology , Mice , Peroxidase/metabolismABSTRACT
Free-living amoebae of the genus Acanthamoeba produce a progressive, blinding infection of the corneal surface. The pathogenesis of Acanthamoeba keratitis involves parasite-mediated cytolysis and phagocytosis of corneal epithelial cells and induction of programmed cell death. Acanthamoeba spp. elaborate a variety of proteases which may facilitate cytolysis of the corneal epithelium, invasion of the extracellular matrix, and dissolution of the corneal stromal matrix.
Subject(s)
Acanthamoeba Keratitis/pathology , Acanthamoeba Keratitis/parasitology , Acanthamoeba/pathogenicity , Acanthamoeba/growth & development , Animals , Cornea/pathology , Humans , MiceABSTRACT
PURPOSE: This study examined the effect of an angiostatic agent on the growth of a highly vascularized intraocular tumor. METHODS: A murine uveal melanoma cell line (99E1) was transplanted intracamerally into athymic nude BALB/c mice. Mice were treated topically three times per day beginning on the day of tumor transplantation and continuing through day 28. Groups included (a) 1% anecortave acetate, (b) vehicle control, or (c) no treatment. Tumor growth was scored clinically according to the volume of anterior chamber occupied by tumor. Intraocular tumor weights were determined on days 10, 14, 21, and 28. The effect of the test agents on tumor cell proliferation was examined in vitro by [3H]thymidine incorporation. RESULTS: Tumors grew progressively in untreated mice and mice treated with the vehicle; tumors filled the entire eye by day 20 and frequently perforated the globe by day 21. By contrast, tumors treated with anecortave acetate grew significantly slower (P < 0.025) and did not perforate the eye. On days 21 and 28 the net tumor weight of the AL-3789-treated animals was 40% to 30% of controls (P < 0.05). Tumor inhibition was presumably due to the angiostatic properties of anecortave acetate because the compound did not affect tumor cell proliferation in vitro. CONCLUSIONS: The topical ocular administration of anecortave acetate restricted the growth of a highly vascularized angiogenic intraocular tumor.
Subject(s)
Anterior Chamber/drug effects , Hydrocortisone/analogs & derivatives , Melanoma, Experimental/drug therapy , Uveal Neoplasms/drug therapy , Administration, Topical , Animals , Anterior Chamber/pathology , Cell Division/drug effects , Female , Hydrocortisone/administration & dosage , Hydrocortisone/therapeutic use , Melanoma, Experimental/blood supply , Melanoma, Experimental/pathology , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Tumor Cells, Cultured , Uveal Neoplasms/blood supply , Uveal Neoplasms/pathologySubject(s)
Acanthamoeba Keratitis/immunology , Acanthamoeba/immunology , Acanthamoeba Keratitis/parasitology , Acanthamoeba Keratitis/prevention & control , Amebiasis/immunology , Amebiasis/parasitology , Amebiasis/prevention & control , Animals , Antigens, Protozoan/administration & dosage , Antigens, Protozoan/immunology , Cricetinae , Humans , Immunization , Langerhans Cells/immunology , Risk FactorsABSTRACT
Acanthamoeba keratitis is a rare, yet sight-threatening corneal infection. Ocular infection does not appear to induce protective immunity as repeated corneal infections occur in both humans and experimental animals. However, we have recently demonstrated that activation of the common mucosal immune system by oral immunization with Acanthamoeba antigens protects both Chinese hamsters and pigs against ocular infection with A. castellanii. Protection correlates closely with the appearance of anti- Acanthamoeba antibodies in the tears. To test the hypothesis that oral immunization induces specific protective IgA antibodies, two monoclonal IgA antibodies specific for Acanthamoeba antigens were generated. Both antibodies detected epitopes on the surface of fixed Acanthamoeba trophozoites. When delivered intraperitoneally, one monoclonal antibody (14E4) was detected in stool and tear samples. This clone also protected naive animals against ocular challenge with Acanthamoeba trophozoites (43% infection rate compared to a 91% infection rate in animals receiving control IgA). In vitro functional studies showed that neither antibody induced encystment or directly killed Acanthamoeba trophozoites. However, both monoclonal anti- Acanthamoeba IgA antibodies produced a three-fold inhibition in the adherence of trophozoites to corneal epithelial cells in vitro. These data show that monoclonal anti- Acanthamoeba IgA antibodies can protect against Acanthamoeba keratitis and suggest that this occurs by inhibiting adhesion of the parasite to the corneal epithelium.
Subject(s)
Acanthamoeba Keratitis/prevention & control , Acanthamoeba/immunology , Antibodies, Monoclonal/therapeutic use , Antibodies, Protozoan/therapeutic use , Immunoglobulin A/therapeutic use , Animals , Blotting, Western , Cell Adhesion/immunology , Cell Line , Cricetinae , Cricetulus , Epithelium, Corneal/parasitology , Immunization, PassiveABSTRACT
PURPOSE: To determine whether oral immunization with Acanthamoeba castellanii antigens elicits mucosal antibodies of the IgA isotype and whether mucosal antibodies affect parasite adhesion to the corneal epithelium. METHODS: Chinese hamsters were immunized with 100 microg aqueous Acanthamoeba antigen mixed with cholera toxin (Ac-CT) and subsequently challenged with parasite-laden contact lenses that were applied to abraded corneal surfaces. Tears and stool samples were examined for the presence of Acanthamoeba-specific IgA antibodies by enzyme-linked immunosorbent assay (ELISA). The effect of mucosal antibody on trophozoite binding to corneal epithelium and viability of trophozoites was examined in vitro. RESULTS: Hamsters immunized orally with Ac-CT showed significantly lower infection rates than did control groups (21.4% versus 72.6%). ELISA analysis of mucosal specimens showed the presence of parasite-specific IgA in stool samples and tears from hamsters orally immunized with Ac-CT, but not in control animals. In vitro assays showed that anti-Acanthamoeba IgA did not affect parasite viability. However, mucosal anti-Acanthamoeba IgA profoundly inhibited (>75%) the binding of parasites to corneal epithelial cells in vitro. CONCLUSIONS: Oral immunization with Ac-CT induces the production of parasite-specific IgA in mucosal secretions and prevents corneal infection. Mucosal antibody does not affect the viability of Acanthamoeba trophozoites but seems to prevent infection by inhibiting parasite binding to the corneal epithelium.
Subject(s)
Acanthamoeba Keratitis/prevention & control , Acanthamoeba/immunology , Antibodies, Protozoan/physiology , Immunoglobulin A, Secretory/physiology , Protozoan Vaccines/administration & dosage , Tears/immunology , Acanthamoeba Keratitis/immunology , Administration, Oral , Animals , Antibodies, Protozoan/analysis , Antigens, Protozoan/immunology , Cornea/immunology , Cornea/parasitology , Cricetinae , Cricetulus , Cytotoxicity, Immunologic , Enzyme-Linked Immunosorbent Assay , Feces/parasitology , Immunity, Mucosal , Immunization , Immunoglobulin A, Secretory/analysis , Mouth Mucosa/immunologyABSTRACT
PURPOSE: To determine whether oral immunization mitigates ongoing Acanthamoeba castellanii corneal infections in pigs. METHODS: Pigs were orally immunized with aqueous Acanthamoeba antigen mixed with cholera toxin (Ac-CT) or with saline, before or after ocular infection with A. castellanii. Mucosal secretions (i.e., tears and enteric wash) were tested for Acanthamoeba-specific IgA by enzyme-linked immunosorbent assay. Enteric washes were used as a source of IgA in assays measuring the binding of trophozoites to Chinese hamster corneal epithelial (CHCE) cells. RESULTS: Pigs immunized with Ac-CT before ocular challenge with A. castellanii had significant anti-Acanthamoeba IgA antibody titers in their tears and enteric washes and were protected against ocular infection. Enteric washes from orally immunized pigs inhibited trophozoite binding to CHCE cells in vitro by more than 75%. By contrast, pigs immunized after corneal infections had been established displayed keratitis of the same severity and duration as that in control pigs. However, 80% of the orally immunized animals were resistant to rechallenge with Acanthamoeba-laden contact lenses, whereas none of the control animals was resistant. CONCLUSIONS: Oral immunization with Ac-CT protects against Acanthamoeba keratitis when administered before corneal challenge. However, delaying oral immunization until after corneal disease is established fails to mitigate keratitis. The appearance of parasite-specific tear IgA correlates with protection and may act by preventing the parasite's binding to the corneal epithelium.
Subject(s)
Acanthamoeba Keratitis/prevention & control , Acanthamoeba/immunology , Antigens, Protozoan/immunology , Immunization/methods , Immunoglobulin A, Secretory/immunology , Tears/immunology , Acanthamoeba Keratitis/immunology , Administration, Oral , Animals , Cricetinae , Cricetulus , Enzyme-Linked Immunosorbent Assay , Epithelium, Corneal/parasitology , Humans , Immunity, Mucosal , Intestinal Mucosa/immunology , Swine , Tissue Adhesions/immunologyABSTRACT
Acanthamoeba keratitis is a chronic inflammatory disease of the cornea which is highly resistant to many antimicrobial agents. The pathogenic mechanisms of this disease are poorly understood. However, it is believed that the initial phases in the pathogenesis of Acanthamoeba keratitis involve parasite binding and lysis of the corneal epithelium. These processes were examined in vitro, using Acanthamoeba castellanii trophozoites. Parasites readily adhered to Chinese hamster corneal epithelial cells in vitro; however, parasite binding was strongly inhibited by mannose but not by lactose. Although mannose prevented trophozoite binding, it did not affect cytolysis of corneal epithelial cells. Moreover, mannose treatment induced trophozoites to release cytolytic factors that lysed corneal epithelial cells in vitro. These factors were uniquely induced by mannose because supernatants collected from either untreated trophozoites or trophozoites treated with other sugars failed to lyse corneal cells. The soluble factors were size fractionated in centrifugal concentrators and found to be > or = 100 kDa. Treatment of the supernatants with the serine protease inhibitor phenylmethylsulfonyl fluoride inhibited most, but not all, of the cytopathic activity. These data suggest that the binding of Acanthamoeba to mannosylated proteins on the corneal epithelium may exacerbate the pathogenic cascade by initiating the release of cytolytic factors.
Subject(s)
Acanthamoeba Keratitis/parasitology , Acanthamoeba/metabolism , Acanthamoeba/pathogenicity , Cytotoxins/metabolism , Mannose/pharmacology , Acanthamoeba Keratitis/metabolism , Animals , Cells, Cultured , Culture Media, Conditioned/pharmacology , Cytotoxins/isolation & purification , Epithelial Cells/parasitology , Epithelium, Corneal/parasitology , Galactose/metabolism , Galactose/pharmacology , Lactose/metabolism , Lactose/pharmacology , Mannose/metabolism , Phenylmethylsulfonyl Fluoride/pharmacologyABSTRACT
Recrudescence is a common and troubling feature of Acanthamoeba keratitis and suggests that corneal infection with this organism fails to stimulate the systemic immune apparatus. The present study examined the cell-mediated and humoral immune responses to Acanthamoeba keratitis in the Chinese hamster. Corneal infection with A. castellanii failed to induce either delayed-type hypersensitivity (DTH) or serum IgG antibody against parasite antigens. The failure to induce cell-mediated and humoral immunity did not result in anergy or tolerance since subsequent intramuscular (i.m.) immunization with parasite antigens elicited robust DTH and IgG antibody responses. The inability of corneal infections to induce primary cell-mediated immune responses was due to the absence of resident antigen-presenting cells in the central cornea because induction of Langerhans cell (LC) migration into the central cornea prior to infection with Acanthamoeba promoted the development of parasite-specific DTH. Although the presence of resident LC did not promote the development of a primary humoral immune response, subsequent i.m. immunization elicited heightened parasite-specific IgG antibody production which was indicative of an anamnestic response. Collectively, the results indicate that in the absence of resident antigen-presenting cells, corneal infection with Acanthamoeba fails to stimulate primary cell-mediated or humoral immunity. Induction of peripheral LC into the central corneal epithelium promotes the development of parasite-specific DTH, but does not exacerbate corneal disease.
Subject(s)
Acanthamoeba Keratitis/immunology , Acanthamoeba/immunology , Antibodies, Protozoan/analysis , Cornea/immunology , Animals , Antibody Formation/immunology , Antigen-Presenting Cells/immunology , Antigens, Protozoan/immunology , Cell Movement , Cornea/parasitology , Cricetinae , Cricetulus , Enzyme-Linked Immunosorbent Assay , Hypersensitivity, Delayed/immunology , Immunity, Cellular/immunology , Immunoglobulin G/analysis , Langerhans Cells/immunologyABSTRACT
Acinetobacter calcoaceticus is a metabolically versatile microorganism that is naturally competent for DNA uptake and incorporation. We have exploited the natural state of competency for studies involving the cloning, organization and expression of genes encoding catabolic enzymes. A. calcoaceticus is able to take up, at high efficiency, genetically engineered DNA, incorporate the DNA and stably maintain and express the DNA. Sequence analysis of cloned A. calcoaceticus DNA reveals a great deal of internal repetition and secondary structure, but no specific sequences associated with uptake appear to be present. Uptake and transformation occurs in solid and liquid medium, at a wide range of DNA concentrations and with little restriction barrier to the source of the transforming DNA.